A Case Series of Metastatic Metaplastic Breast Carcinoma Treated With Anti-PD-1 Therapy

Metaplastic breast cancer is a rare and often chemo-refractory subtype of breast cancer with poor prognosis and limited treatment options. Recent studies have reported overexpression of programmed death ligand 1 (PD-L1) in metaplastic breast cancers, and there are several reports of anti-PD-1/L1 bei...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Isaac, Rajamanickam, Venkatesh, Bernard, Brady, Chun, Brie, Wu, Yaping, Martel, Maritza, Sun, Zhaoyu, Redmond, William L., Sanchez, Katherine, Basho, Reva, McArthur, Heather, Page, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217650/
https://www.ncbi.nlm.nih.gov/pubmed/34168978
http://dx.doi.org/10.3389/fonc.2021.635237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217650/
https://www.ncbi.nlm.nih.gov/pubmed/34168978
http://dx.doi.org/10.3389/fonc.2021.635237

Ejemplares similares